ATE274913T1 - Wässerige zusammensetzung enthaltend amphotericin b - Google Patents
Wässerige zusammensetzung enthaltend amphotericin bInfo
- Publication number
- ATE274913T1 ATE274913T1 AT01923963T AT01923963T ATE274913T1 AT E274913 T1 ATE274913 T1 AT E274913T1 AT 01923963 T AT01923963 T AT 01923963T AT 01923963 T AT01923963 T AT 01923963T AT E274913 T1 ATE274913 T1 AT E274913T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- amphotericin
- composition containing
- aqueous composition
- containing amphotericin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN217MU2001 IN188924B (de) | 2001-03-01 | 2001-03-01 | |
PCT/IN2001/000040 WO2002069983A1 (en) | 2001-03-01 | 2001-03-16 | Amphotericin b aqueous composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE274913T1 true ATE274913T1 (de) | 2004-09-15 |
Family
ID=11097223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01923963T ATE274913T1 (de) | 2001-03-01 | 2001-03-16 | Wässerige zusammensetzung enthaltend amphotericin b |
Country Status (23)
Country | Link |
---|---|
US (1) | US20040137049A1 (de) |
EP (1) | EP1368041B1 (de) |
JP (1) | JP2004523566A (de) |
KR (1) | KR100810067B1 (de) |
CN (1) | CN1255114C (de) |
AT (1) | ATE274913T1 (de) |
AU (1) | AU2001250643B2 (de) |
BG (1) | BG108188A (de) |
BR (1) | BR0116922A (de) |
CA (1) | CA2438847A1 (de) |
CZ (1) | CZ20032264A3 (de) |
DE (1) | DE60105322T2 (de) |
DK (1) | DK1368041T3 (de) |
EA (1) | EA006241B1 (de) |
ES (1) | ES2227172T3 (de) |
IN (1) | IN188924B (de) |
MX (1) | MXPA03007777A (de) |
NZ (1) | NZ528281A (de) |
PT (1) | PT1368041E (de) |
SK (1) | SK10742003A3 (de) |
WO (1) | WO2002069983A1 (de) |
YU (1) | YU75403A (de) |
ZA (1) | ZA200307307B (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
JP2006069929A (ja) * | 2004-08-31 | 2006-03-16 | Konica Minolta Medical & Graphic Inc | 真菌症治療製剤およびその製造方法 |
WO2006030450A2 (en) * | 2004-09-13 | 2006-03-23 | Bharat Serums & Vaccines Ltd. | Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
CN100418536C (zh) * | 2005-04-06 | 2008-09-17 | 河南省眼科研究所 | 一种用于眼科的抗真菌药物组合物 |
CN101453982B (zh) | 2006-05-30 | 2011-05-04 | 精达制药公司 | 两件式内部通道渗透递送系统流动调节器 |
WO2008021133A2 (en) | 2006-08-09 | 2008-02-21 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
EP2157967B1 (de) | 2007-04-23 | 2013-01-16 | Intarcia Therapeutics, Inc | Suspensionsformulierungen insulinotroper peptide und ihre verwendung |
EP2240155B1 (de) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe |
CN104323981B (zh) | 2009-09-28 | 2019-03-12 | 精达制药公司 | 基本稳态药物递送的快速建立和/或终止 |
KR101629521B1 (ko) * | 2010-03-16 | 2016-06-13 | 우석대학교 산학협력단 | 난용성 약물 가용화 및 생체막 투과증진을 위한 알코올성 수상을 내상으로 하는 리포좀, 리포좀 조성물 및 리포좀의 제조방법 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
CN102525921B (zh) * | 2012-02-06 | 2013-08-07 | 西安力邦制药有限公司 | 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法 |
WO2013142184A1 (en) * | 2012-03-19 | 2013-09-26 | Yale University | Antimicrobial compositions and methods |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
WO2016196851A2 (en) | 2015-06-03 | 2016-12-08 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
EP3222324B1 (de) * | 2016-03-23 | 2020-05-13 | Wayne State University | Valproat als topische antimykotische behandlung |
MX2018014016A (es) | 2016-05-16 | 2019-08-01 | Intarcia Therapeutics Inc | Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos. |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
CN110225762A (zh) | 2017-01-03 | 2019-09-10 | 因塔西亚制药公司 | 包括glp-1受体激动剂的连续施用和药物的共同施用的方法 |
CN108344811A (zh) * | 2017-01-24 | 2018-07-31 | 北京泰德制药股份有限公司 | 一种注射用脂质体中有机溶剂残留的检测方法 |
CN108309955B (zh) * | 2018-04-27 | 2020-06-02 | 武昌理工学院 | 一种聚明胶肽结合型紫杉醇纳米颗粒的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1338736C (fr) * | 1986-12-05 | 1996-11-26 | Roger Baurain | Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation |
US5616334A (en) * | 1987-03-05 | 1997-04-01 | The Liposome Company, Inc. | Low toxicity drug-lipid systems |
US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
FR2651680B1 (fr) * | 1989-09-14 | 1991-12-27 | Medgenix Group Sa | Nouveau procede de preparation de microparticules lipidiques. |
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
JP3956402B2 (ja) * | 1996-03-04 | 2007-08-08 | 日本油脂株式会社 | アンホテリシンb運搬体 |
US6180136B1 (en) * | 1998-11-10 | 2001-01-30 | Idexx Laboratories, Inc. | Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
-
2001
- 2001-03-01 IN IN217MU2001 patent/IN188924B/en unknown
- 2001-03-16 PT PT01923963T patent/PT1368041E/pt unknown
- 2001-03-16 ES ES01923963T patent/ES2227172T3/es not_active Expired - Lifetime
- 2001-03-16 EP EP01923963A patent/EP1368041B1/de not_active Expired - Lifetime
- 2001-03-16 MX MXPA03007777A patent/MXPA03007777A/es active IP Right Grant
- 2001-03-16 JP JP2002569158A patent/JP2004523566A/ja active Pending
- 2001-03-16 CA CA002438847A patent/CA2438847A1/en not_active Abandoned
- 2001-03-16 US US10/469,624 patent/US20040137049A1/en not_active Abandoned
- 2001-03-16 NZ NZ528281A patent/NZ528281A/en not_active IP Right Cessation
- 2001-03-16 SK SK1074-2003A patent/SK10742003A3/sk unknown
- 2001-03-16 AU AU2001250643A patent/AU2001250643B2/en not_active Ceased
- 2001-03-16 YU YU75403A patent/YU75403A/sh unknown
- 2001-03-16 KR KR1020037011489A patent/KR100810067B1/ko not_active IP Right Cessation
- 2001-03-16 AT AT01923963T patent/ATE274913T1/de not_active IP Right Cessation
- 2001-03-16 CN CNB018231632A patent/CN1255114C/zh not_active Expired - Fee Related
- 2001-03-16 DE DE60105322T patent/DE60105322T2/de not_active Expired - Lifetime
- 2001-03-16 DK DK01923963T patent/DK1368041T3/da active
- 2001-03-16 EA EA200300948A patent/EA006241B1/ru not_active IP Right Cessation
- 2001-03-16 BR BR0116922-0A patent/BR0116922A/pt active Search and Examination
- 2001-03-16 CZ CZ20032264A patent/CZ20032264A3/cs unknown
- 2001-03-16 WO PCT/IN2001/000040 patent/WO2002069983A1/en active IP Right Grant
-
2003
- 2003-09-18 ZA ZA200307307A patent/ZA200307307B/en unknown
- 2003-09-23 BG BG108188A patent/BG108188A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
JP2004523566A (ja) | 2004-08-05 |
DE60105322T2 (de) | 2005-09-15 |
SK10742003A3 (sk) | 2004-01-08 |
ZA200307307B (en) | 2004-04-20 |
CZ20032264A3 (cs) | 2003-12-17 |
IN188924B (de) | 2002-11-23 |
BG108188A (bg) | 2004-09-30 |
CA2438847A1 (en) | 2002-09-12 |
EP1368041B1 (de) | 2004-09-01 |
KR100810067B1 (ko) | 2008-03-05 |
AU2001250643B2 (en) | 2007-03-22 |
CN1505519A (zh) | 2004-06-16 |
DE60105322D1 (de) | 2004-10-07 |
US20040137049A1 (en) | 2004-07-15 |
WO2002069983A1 (en) | 2002-09-12 |
DK1368041T3 (da) | 2005-01-17 |
CN1255114C (zh) | 2006-05-10 |
ES2227172T3 (es) | 2005-04-01 |
EA006241B1 (ru) | 2005-10-27 |
KR20040018337A (ko) | 2004-03-03 |
EA200300948A1 (ru) | 2004-04-29 |
BR0116922A (pt) | 2004-04-27 |
NZ528281A (en) | 2006-11-30 |
YU75403A (sh) | 2006-05-25 |
MXPA03007777A (es) | 2003-12-08 |
PT1368041E (pt) | 2005-01-31 |
EP1368041A1 (de) | 2003-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE274913T1 (de) | Wässerige zusammensetzung enthaltend amphotericin b | |
CY1120462T1 (el) | Τοπικες ανθελμινθικες κτηνιατρικες τυποποιησεις | |
WO2001092288A3 (en) | Cobalamin compounds useful as antibiotic agents and as imaging agents | |
BR0112461A (pt) | Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada | |
UA94901C2 (ru) | Антибактериальные производные пиперидина | |
CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
CY1112560T1 (el) | Πνευμονικη μεταφορα των αμινογλυκοσιδων | |
SE0102315D0 (sv) | Compounds | |
TR200302242T2 (tr) | Protein kinaz önleyicileri olarak pirolopirimidinler | |
BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
BR0207760A (pt) | Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição | |
IT1313610B1 (it) | Processo per la preparazione di formulazioni acquose per uso oftalmico | |
CY1110332T1 (el) | Παραγωγα βενζιμιδαζολης, συνθεσεις που τα περιεχουν, παρασκευη αυτων και χρηση τους | |
CY1110664T1 (el) | Ενδορινικες συνθεσετς | |
MY135850A (en) | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | |
ATE386725T1 (de) | Heterocyclylverbindungen | |
ES2186550A1 (es) | Nuevos derivados de oxazolidinonas como antibacterianos. | |
NO20005497D0 (no) | Heterocykliske derivater som inhiberer faktor Xa | |
HK1120794A1 (en) | Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them | |
MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
WO2003090744A8 (en) | Antibacterial compositions comprising metal phthalocyanine analogues | |
NO20074167L (no) | Peptidiske forbindelser | |
CY1106711T1 (el) | Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους | |
PT1411956E (pt) | Utilizacao de polissacaridos sobre-sulfatados como inibidores de vih | |
DE60003074D1 (de) | Fusidinsäure-derivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1368041 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |